BHVN Award Disclosure
Gentile Kimberly · SEC Form 4 · Filed Sep 17, 2026
Award
Calculated transaction value
$0
Gentile Kimberly SVP, Clinical Operations
BHVN
Biohaven Ltd
BHVN
Transaction date
Sep 15, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 2 days later
BHVN daily price context
Close on/before transaction
$12.34
Sep 15, 2026
Close before public filing
$12.02
Sep 16, 2026
Return since public filing
+13.31%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Options (Right to buy) on Common Shares
- Quantity / price
- 1,000 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001704186-26-000006
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Biohaven Ltd. BHVN Current | Award | Sep 15, 2026 | $0 |